Clinical Trial Update: Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating enzalutamide with or without abiraterone and prednisone in castration-resistant metastatic prostate cancer; status and results not prov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)
• Enzalutamide (enzalutamide)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer | Phase 3 | Status: UNKNOWN | Results posted: 2020-06-01